Abstract:Objective: To investigate the effects of 15-deoxy-prostaglandin J2 (15d-PGJ2), a peroxisome proliferatoractivated receptor γ (PPARγ) endogenous ligand, on proliferation and apoptosis of human HepG2 cells and to explore the potential mechanism. Methods: 15d-PGJ2 at different concentrations was used to treat the HepG2 cells cultured in vitro, MTT colorimetry was employed to measure proliferation of the cells, and 3H-TdR uptake test was used to measure the synthetic rate of the cells. The expressions of PPARγ mRNA and protein were measured by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Cell apoptosis rate and cell cycle were analyzed by flow cytometry (FCM). And the effects of PPARγ-specific antagonist (GW9662) and/or transient transfection pSG5-PPARγ eukaryotic expression plasmid on proliferation of the HepG2 cells were also observed, and pGCsi-PPARγ was used to transfect the cells to observe the effects of 15d-PGJ2 on proliferation of the HepG2 cells in the silence of PPARγ. The DNA binding activity of NF-κB was detected by electrophoretic mobility shift assay (EMSA). Results: 15d-PGJ2 at different concentrations inhibited cell proliferation, DNA synthetic rate and induced apoptosis in a dose-dependent manner in HepG2 cells; in this process, the proportion of G0/G1 phase cells increased significantly while the proportion of S phase cells decreased significantly, and the expression levels of PPARγ mRNA and protein were not changed. GW9662 antagonized the proliferation inhibition effect of 15d-PGJ2, but didn’t block completely. However, transfection with a PPARγ-pSG5 expression plasmid restored the effect of 15d-PGJ2 on cell growth in presence of GW9662. After transfection with pGCsi-PPARγ, 15d-PGJ2 also inhibited cell proliferation at 20 μmol·L-1. Furthermore, 15d-PGJ2 inhibited the DNA binding activity of NF-κB at a higher concentration (50 μmol·L -1). Conclusion: 15d-PGJ2 inhibits cell growth, induces apoptosis and interferes with cell cycle of the HepG2 cells, which indicates that the activation of PPARγ is anti-neoplastic in HCC. This effect involves the PPARγ-dependent and PPARγ-independent pathways, which is related to the inhibition of NF-κB signaling pathway.

Preliminary studies of blocking VEGF and EGFR signal pathway on proliferation of HepG2 cells

Sbudies on the Effect of Parthenolide on the Proliferation of Rat Vascular Smooth Muscle Cells and the Mechanism

The Effect of Anti-vascular Endothelial Growth Factor and Receptor Antibody on the Proliferation Activity and Apoptosis of Human Gastric Cancer

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Effects of Inhibit Extracellular-Signal Regulated Kinase 1/2 Pathway on Apoptosis of Hepatoma Carcinoma Cell SMMC-7721

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Effects of PolyphyllinⅡ in Growth Inhibition of Human Breast Cancer Cells

Nidus Vespae Protein Inhibiting Proliferation of Hepg2 Hepatoma Cells Through Extracellular Signal-Regulated Kinase Signaling Pathways and Inducing G(1) Cell Cycle Arrest

Effect of inhibition of Hedgehog signaling pathway on the growth and migration of hepatocellular carcinoma cells

siRNA against signal transducer and activator of transcription 3 inhibits proliferation of HepG2 cells in vitro

[Effects of Vascular Endothelial Growth Factor (VEGF) Antisense Oligodeoxynucleotide on Mrna and Expression of VEGF, Flt-1, and Kinase Insert Domain Containing Receptor and VEGF Excretion in Human Gallbladder Carcinoma Cells].

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

Effect of down-regulating histone methyltransferase gene KMT2C with shRNA interference on the proliferation of hepatocellular carcinoma cell line HepG2 and its mechanism

Inhibitory Effect of EGCG on Proliferation and HIF-1α/VEGF Expression in Cell Line HepG2

Effects of vitamin D analogues EB1089 on proliferation, apoptosis and invasion of heptocellular cells

Inhibitory effect and mechanism of Brivanib on HepG2 cells

The Effects of ~(18)F-FDG on the Proliferation of HepG2 Liver Cancer Cells

Effect of Interferon-Gamma on the Expression of Vascular Endothelial Growth Factor C on Hep-2 Laryngeal Carcinoma Cell Lines

Epidermal Growth Factor Receptor Inhibitor AG1478 Affects HepG2 Cell Proliferation, Cell Cycle, Apoptosis and C-Myc Protein Expression in a Dose-Dependent Manner

Effects and mechanism of 15-deoxy-prostaglandin J 2 on proliferation and apoptosis of human HepG 2 cells

The study of vitamin D analogue EB1089 on the proliferation of hepatocellular carcinoma cells